EGFR Exon 20

Advertisement

cGxPJobs Banner

Zipalertinib Advances With FDA Rolling NDA Submission

PRINCETON, NJ — November 20 , 2025 — Taiho Oncology, Taiho Pharmaceutical, and Cullinan Therapeutics announced the initiation of...

By cGxPwire Editor
November 21, 2025

Read More

Advertisement

cGxPJobs

Directory